513PPreventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer. (25th November 2018) - Su, P-L; Wu, Y-L; Chang, W-Y; Su, W-C; Yang, S-C; Lin, C-C